162 related articles for article (PubMed ID: 8031927)
1. Determination of enantiomeric purity of nicotine in pharmaceutical preparations by 13C-NMR in the presence of a chiral lanthanide shift reagent.
Jaroszewski JW; Olsson A
J Pharm Biomed Anal; 1994 Mar; 12(3):295-9. PubMed ID: 8031927
[TBL] [Abstract][Full Text] [Related]
2. Enantiomeric purity determination of acetyl-L-carnitine by NMR with chiral lanthanide shift reagents.
Kagawa M; Machida Y; Nishi H; Haginaka J
J Pharm Biomed Anal; 2005 Aug; 38(5):918-23. PubMed ID: 16024206
[TBL] [Abstract][Full Text] [Related]
3. 1H NMR studies of drugs with achiral and chiral lanthanide shift reagents: applications to the anticonvulsant pheneturide.
Byrne B; Rothchild R
Chirality; 1999; 11(7):529-35. PubMed ID: 10423278
[TBL] [Abstract][Full Text] [Related]
4. Determination of enantiomeric purity of tranylcypromine sulfate by proton magnetic resonance spectroscopy with chiral lanthanide shift reagent.
Hanna GM; Lau-Cam CA
J Assoc Off Anal Chem; 1989; 72(4):552-5. PubMed ID: 2759984
[TBL] [Abstract][Full Text] [Related]
5. Optical purity determination of threo-methylphenidate hydrochloride using a chiral europium nuclear magnetic resonance (NMR) shift reagent.
Hanna GM; Lau-Cam CA
Pharm Res; 1990 Jul; 7(7):726-9. PubMed ID: 2395800
[TBL] [Abstract][Full Text] [Related]
6. Direct enantiomeric purity determination of the chiral anesthetic drug bupivacaine by 1H NMR spectroscopy.
Hanna GM
Pharmazie; 2001 Apr; 56(4):314-7. PubMed ID: 11338671
[TBL] [Abstract][Full Text] [Related]
7. Optical purity determination by NMR: use of chiral lanthanide shift reagents and a base line technique.
Dewar GH; Kwakye JK; Parfitt RT; Sibson R
J Pharm Sci; 1982 Jul; 71(7):802-6. PubMed ID: 7120067
[TBL] [Abstract][Full Text] [Related]
8. Determination of the optical purity of timolol maleate by proton nuclear magnetic resonance spectroscopy with a chiral Pr(III) shift reagent.
Hanna GM; Lau-Cam CA
J Pharm Biomed Anal; 1995 Oct; 13(11):1313-9. PubMed ID: 8634348
[TBL] [Abstract][Full Text] [Related]
9. NMR regulatory analysis: enantiomeric purity determination for (R)-(-)-desoxyephedrine and antipode methamphetamine.
Hanna GM
Pharmazie; 2006 Mar; 61(3):188-93. PubMed ID: 16599257
[TBL] [Abstract][Full Text] [Related]
10. Optical purity determination, conformer populations and 1H NMR spectral simplification with lanthanide shift reagents--part IX. A method for improved analytical precision for "DOEt", 2,5-dimethoxy-4-ethylamphetamine.
Hatzis A; Rothchild R
J Pharm Biomed Anal; 1987; 5(2):119-29. PubMed ID: 16867532
[TBL] [Abstract][Full Text] [Related]
11. Determination of the optical purity and absolute configuration of threo-methylphenidate by proton nuclear magnetic resonance spectroscopy with chiral solvating agent.
Hanna GM; Lau-Cam CA
J Pharm Biomed Anal; 1993 Aug; 11(8):665-70. PubMed ID: 8257731
[TBL] [Abstract][Full Text] [Related]
12. Enantiomeric differentiation of oxygenated p-menthane derivatives by 13C NMR using Yb(hfc)3.
Lanfranchi DA; Blanc MC; Vellutini M; Bradesi P; Casanova J; Tomi F
Magn Reson Chem; 2008 Dec; 46(12):1188-94. PubMed ID: 18828150
[TBL] [Abstract][Full Text] [Related]
13. Determination of the enantiomeric composition of carprofen by proton nuclear magnetic resonance spectroscopy with a chiral lanthanide-shift reagent.
Hanna GM; Lau-Cam CA
Talanta; 1989 Sep; 36(9):883-7. PubMed ID: 18964827
[TBL] [Abstract][Full Text] [Related]
14. Nonequivalence behavior studies for the direct determination of enantiomeric purity and absolute configuration of timolol by NMR.
Hanna GM
Pharmazie; 2004 Dec; 59(12):923-8. PubMed ID: 15638079
[TBL] [Abstract][Full Text] [Related]
15. Assignment of the side-chain 1H and 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy.
Clore GM; Bax A; Driscoll PC; Wingfield PT; Gronenborn AM
Biochemistry; 1990 Sep; 29(35):8172-84. PubMed ID: 2261471
[TBL] [Abstract][Full Text] [Related]
16. Optical purity determination and (1)H-NMR spectral simplification with lanthanide shift reagents - VIII. An indacrinone precursor, 6,7-dichloro-5-methoxy-2-methyl-2-phenyl-1-indanone.
Hatzis A; Rothchild R
J Pharm Biomed Anal; 1986; 4(4):443-9. PubMed ID: 16867580
[TBL] [Abstract][Full Text] [Related]
17. 1H-NMR studies of drugs with chiral solvating agent: the direct enantiomeric purity determination of the chiral anesthetic, prilocaine.
Hanna GM
Enantiomer; 2000; 5(3-4):303-12. PubMed ID: 11126871
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the uses of lanthanide NMR shift probes in the determination of protein structure in solutio. Application to the EF calcium binding site of carp parvalbumin.
Lee L; Sykes BD
Biophys J; 1980 Oct; 32(1):193-210. PubMed ID: 7248448
[TBL] [Abstract][Full Text] [Related]
19. Determination of enantiomeric homogeneity (optical purity) of cyclophosphamide by nuclear magnetic resonance spectroscopy.
Zon G; Brandt JA; Egan W
J Natl Cancer Inst; 1977 Apr; 58(4):1117-9. PubMed ID: 845982
[TBL] [Abstract][Full Text] [Related]
20. Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine.
Salsbury JS; Isbester PK
Magn Reson Chem; 2005 Nov; 43(11):910-7. PubMed ID: 16052604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
